Health Condition 1: I00-I99- Diseases of the circulatory system
Conditions
Interventions
Intervention1: Propofol 2ml (2mg/kg): propofol-saline (PS): 2 ml. 0.9% sodium chloride as control
Intervention2: Propofol 2ml (2mg/kg): propofol-phenylephrine (PP): 2 ml (25 mcg/ml) phenylephrine
Inte
Sponsors
Department Of Anesthesiology and Critical Care
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients undergoing elective surgery under general anaesthesia. 2.Patients aged 18-60 years. 3.Patients of either sex. 4.Patients coming under American Society of Anesthesiologists physical status I,II(Annexure I).
Exclusion criteria
Exclusion criteria: 1.Patients who are unwilling to participate in the study 2.Patients who are allergic to any of the study drugs 3.Patients scheduled for emergency surgery 4.Patients with history of uncontrolled hypertension and diabetes mellitus 5.Peripheral vascular disease 6.Ischemic heart disease 7.Cardiac arrhythmias 8.Morbid obesity (BMI >35 kg/m2) 9.Pregnant and lactating women 10.Patients with psychiatric abnormalities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate , systolic blood pressure , diastolic blood pressure and mean arterial pressure will be recorded.Timepoint: Heart rate, systolic blood pressure, diastolic blood pressure and mean arterial pressure are Measured at first, second, third, fourth and fifth minute immediately after induction with propofol | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of episodes of hypertension, hypotension, bradycardia and tachycardiaTimepoint: during study period. | — |
Countries
India
Contacts
Public ContactDr Aloka Samantaray
Sri Venkateshwara Institute Of Medical Science
Outcome results
None listed